Market Cap | 26.62M | P/E | - | EPS this Y | 43.10% | Ern Qtrly Grth | - |
Income | -70.23M | Forward P/E | -0.27 | EPS next Y | -69.00% | 50D Avg Chg | 13.00% |
Sales | 325k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -41.00% |
Dividend | N/A | Price/Book | 1.51 | EPS next 5Y | - | 52W High Chg | -86.00% |
Recommedations | 3.00 | Quick Ratio | 1.29 | Shares Outstanding | 67.63M | 52W Low Chg | 71.00% |
Insider Own | 0.86% | ROA | -50.00% | Shares Float | 60.63M | Beta | 1.58 |
Inst Own | 29.93% | ROE | -161.14% | Shares Shorted/Prior | 1.38M/1.81M | Price | 0.39 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 1,265,145 | Target Price | 0.34 |
Oper. Margin | -20,644.31% | Earnings Date | Feb 13 | Volume | 764,531 | Change | 0.00% |
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.
Wells Fargo | Equal-Weight | Oct 25, 22 |
HC Wainwright & Co. | Neutral | Oct 25, 22 |
Wedbush | Neutral | Oct 24, 22 |
Stifel | Hold | Oct 24, 22 |
Wells Fargo | Equal-Weight | Oct 4, 22 |
Stifel | Buy | Sep 30, 22 |
HC Wainwright & Co. | Buy | Sep 30, 22 |
BTIG | Neutral | Sep 29, 22 |
Chardan Capital | Buy | Sep 28, 22 |